Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trials
Ole Köhler‐Forsberg(Aarhus University), Andrew A. Nierenberg(Andrews University), Mauricio Tohen(University of New Mexico), Richard C. Shelton(University of Maryland, College Park), Melvin G. McInnis(University of Michigan), Joseph R. Calabrese(Case Western Reserve University), Vicki Fung(Massachusetts General Hospital), Lindsay Overhage(Cambridge Health Alliance), Thilo Deckersbach(Harvard University), Terence A. Ketter(Stanford University), Dan V. Iosifescu(Nathan Kline Institute for Psychiatric Research), Michael J. Ostacher(VA Palo Alto Health Care System), Susan L. McElroy(Southwestern Medical Center), Charles L. Bowden(Texas Tech University), Michael E. Thase(Unknown), Louisa G. Sylvia(Massachusetts General Hospital), James H. Kocsis(Cornell University), Edward S. Friedman(University of Pittsburgh)
Cited by 8
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754